2m 2m 2m 2m 2m 2m 2m
Omeros (OMER)
NASDAQ
$18.56+$0.09 (+0.47%)
Price as of Oct 02, 2026 6:05 PM EDT- $1.3BMarket Cap
- 337.68%1-Year Change
- BiotechnologyIndustry
Omeros (OMER)
$18.56+$0.09 (+0.47%)
OMER | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.47 | ||
Change | -$0.57 (-2.99%) | ||
Open | $18.87 | ||
High | $19.20 | ||
Low | $18.47 | ||
Previous Close | $19.04 | ||
Volume | 1,236,859 | ||
30-Day Average Volume | 1,504,457 | ||
1-Week Change | -8.25% | ||
1-Month Change | -1.49% | ||
1-Year Change | 337.68% | ||
3-Year Change | 532.53% | ||
5-Year Change | 116.28% | ||
Fundamentals | |||
Shares Outstanding | 72.4M | ||
Total Assets | $286.8M | ||
Market Cap | $1.3B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $28.5M | ||
Net Income | $13.2M | ||
Free Cash Flow | $4.1M | ||
EBIT | $16.4M | ||
EBITDA | $16.6M | ||
Net Working Capital | $90.3M | ||
EPS | $0.15 | ||
Enterprise Value/EBITDA | 88 | ||
Enterprise Value/Revenue | 51 | ||
P/B | -26 | ||
P/E | 123 | ||
PEG | -2 | ||
Price/Free Cash Flow | 326 | ||
Price/Operating Cash Flow | 322 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue